BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Talks.cam//talks.cam.ac.uk//
X-WR-CALNAME:Talks.cam
BEGIN:VEVENT
SUMMARY:BSU Seminar: &quot\;Effective Health Technologies Faster? Value-Ba
 sed\, Response Adaptive Learning in Clinical Trials&quot\; - Professor Ste
 phen Chick\, INSEAD
DTSTART:20250930T130000Z
DTEND:20250930T140000Z
UID:TALK234904@talks.cam.ac.uk
CONTACT:Alison Quenault
DESCRIPTION:Clinical trials are used to evaluate the health benefit of new
  health technologies\, such as pharmaceuticals\, but are quite costly and 
 therefore have been the subject of much study. Health technology adoption 
 decisions are often made based on not only health benefit\, but the costs 
 of drugs and treatment processes. Is it possible that this mismatch betwee
 n incentives at different steps of the health innovation pipeline\, clinic
 al effectiveness on the one hand and cost-effectiveness on the other\, may
  lead to suboptimal decisions? We introduce and explore a stream of work t
 hat seeks to improve the allocation of resources to clinical trials in a w
 ay that balances health value\n for money for treatments that are ultimate
 ly approved. The stream uses work from Bayesian sequential optimal learnin
 g and from game theory. We first look at basic trade-offs in a simple two-
 arm fully sequential trial design\, to balance the costs of collecting mor
 e trial data with the expected opportunity costs averted by making decisio
 ns with better information. We then explore how the theory can apply to UK
 -NIHR funded clinical trials (including retrospective looks at the ProFHER
  trial\, the CACTUS trial\, and the HERO trial)\, and overview extensions 
 that allow the framework to apply to multiarm trials\, precision medicine 
 trials\, and explore implications for conditional approval schemes (motiva
 ted by the UK Cancer Drugs Fund).
LOCATION:Large Seminar Room\, East Forvie Building\, Forvie Site Robinson 
 Way Cambridge CB2 0SR.
END:VEVENT
END:VCALENDAR
